MicroRNA-128-3p Alleviates Neuropathic Pain Through Targeting ZEB1
- 8 April 2020
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 729, 134946
- https://doi.org/10.1016/j.neulet.2020.134946
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Conditioned place preference and spontaneous dorsal horn neuron activity in chronic constriction injury model in ratsPain, 2015
- Overview of MicroRNA BiologySeminars in Liver Disease, 2015
- Emerging roles of microRNAs in chronic painNeurochemistry International, 2014
- MicroRNA-based therapy in pain medicine: Current progress and future prospectsActa Anaesthesiologica Taiwanica, 2013
- Epithelial–Mesenchymal Transition and Tumor Suppression Are Controlled by a Reciprocal Feedback Loop between ZEB1 and Grainyhead-like-2Cancer Research, 2013
- Neuroinflammation and the generation of neuropathic painBritish Journal of Anaesthesia, 2013
- Cytokine Modulation is Necessary for Efficacious Treatment of Experimental Neuropathic PainJournal of Neuroimmune Pharmacology, 2012
- ZEB proteins link cell motility with cell cycle control and cell survival in cancerCell Cycle, 2010
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nature Reviews Cancer, 2007
- Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteinsThe EMBO Journal, 2003